Sign Up Today and Learn More About Treeline Biosciences Stock
Invest in or calculate the value of your shares in Treeline Biosciences or other pre-IPO companies through EquityZen's platform.
Treeline Biosciences Stock (TRBS)
Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.
About Treeline Biosciences Stock
Founded
2021
Headquarters
Stamford, CT, US
Industries
Software, Artificial Intelligence, Data and Analytics
Treeline Biosciences Press Mentions
Stay in the know about the latest news on Treeline Biosciences
Secretive Treeline Biosciences discloses $421M financing in filing
endpts • Oct 18, 2024
Pyridopyrimidine kras inhibitors
patents • Apr 14, 2024
Quinolone bcl6 bifunctional degraders
patents • Apr 14, 2024
Tricyclic quinolone bcl6 bifunctional degraders
patents • Apr 14, 2024
1,8-naphthyridin-2-one heterobifunctional bcl6 degraders
patents • Apr 14, 2024
Treeline Biosciences Management
Leadership team at Treeline Biosciences
SVP Corporate Development
Spencer Smith
CEO & Co-Founder
Josh Bilenker
Join now and verify your accreditation status to gain access to:
- Treeline Biosciences current valuation
- Treeline Biosciences stock price
- Available deals in Treeline Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Treeline Biosciences Stock
How to invest in Treeline Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Treeline Biosciences through EquityZen funds. These investments are made available by existing Treeline Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Treeline Biosciences stock?
Shareholders can sell their Treeline Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
